Warburg To Make Partial Exit From China Biologic

Login to View

Private equity firm Warburg Pincus LLC is to sell 2.77 million shares of portfolio company China Biologic Products in a partial exit, according to a company announcement.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in